posted on 2016-01-13, 00:00authored byJ.L. Larson, M.K. Covey, M.C. Kapella, C.G. Alex, E. McAuley
Background: People with chronic obstructive pulmonary disease lead sedentary lives and could
benefit from increasing their physical activity. The purpose of this study was to determine if
an exercise-specific self-efficacy enhancing intervention could increase physical activity and
functional performance when delivered in the context of 4 months of upper body resistance
training with a 12-month follow-up.
Methods: In this randomized controlled trial, subjects were assigned to: exercise-specific selfefficacy
enhancing intervention with upper body resistance training (SE-UBR), health education
with upper body resistance training (ED-UBR), or health education with gentle chair exercises
(ED-Chair). Physical activity was measured with an accelerometer and functional performance
was measured with the Functional Performance Inventory. Forty-nine people with moderate
to severe chronic obstructive pulmonary disease completed 4 months of training and provided
valid accelerometry data, and 34 also provided accelerometry data at 12 months of follow-up.
The self-efficacy enhancing intervention emphasized meeting physical activity guidelines and
increasing moderate-to-vigorous physical activity.
Results: Differences were observed in light physical activity (LPA) after 4 months of
training, time by group interaction effect (P=0.045). The SE-UBR group increased time
spent in LPA by +20.68±29.30 minutes/day and the other groups decreased time spent in LPA
by -22.43±47.88 minutes/day and -25.73±51.76 minutes/day. Changes in LPA were not sustained
at 12-month follow-up. There were no significant changes in moderate-to-vigorous physical
activity, sedentary time, or functional performance. Subjects spent most of their waking hours
sedentary: 72%±9% for SE-UBR, 68%±10% for ED-UBR, and 74%±9% for ED-Chair.
Conclusion: The self-efficacy enhancing intervention produced a modest short-term increase
in LPA. Further work is needed to increase the magnitude and duration of effect, possibly by
targeting LPA
Funding
This research was funded by the National Institute of
Nursing Research R01-NR08037 and the University of
Illinois at Chicago General Clinical Research Center
M01-RR-13987. The Clinical Trials Registration number
is NCT01057797